Better glucose control can help people with diabetes who have a common type of stroke to preserve their cognitive function, according to a study accepted for presentation at ENDO 2020, the Endocrine Society's annual meeting. ...
Mar 30, 2020
0
1
(HealthDay)—Having diabetes, poor glycemic control, and longer diabetes duration are associated with worse cognitive outcomes in older adults during a median follow-up of five years, according to a study recently published ...
Jun 19, 2019
0
3
(HealthDay)—For patients with newly diagnosed type 2 diabetes, visit-to-visit hemoglobin A1c (HbA1c) variability is associated with increased risks for cardiovascular disease and microvascular complications, according to ...
Nov 19, 2019
0
1
(HealthDay)—Internet-based psycho-educational programs are beneficial for young patients with type 1 diabetes as they transition into adolescence, according to a study published online April 11 in Diabetes Care.
Apr 22, 2013
0
0
(HealthDay)—Among healthy middle-aged adults, adiposity and hyperglycemia correlate with poor cognitive performance, according to a study published online Dec. 28 in Diabetes Care.
Feb 1, 2013
1
0
An ethnic population at high risk for Type 2 diabetes achieved significant control of the disease through participation in community-based health programs, demonstrating that active intervention and culturally-sensitive education ...
Jan 31, 2018
0
9
(HealthDay)—Proprotein convertase subtilisin/kexin type 9 (PCSK9) is increased in young females and youth with type 1 diabetes (T1D), according to research published online June 6 in Diabetes Care.
Jun 20, 2017
0
0
(HealthDay)—For children, teens, and young adults with type 1 diabetes mellitus (T1DM), hemoglobin A1c (HbA1c) is associated with better diabetes-specific health-related quality of life (D-HRQoL), according to a study published ...
Jun 6, 2017
0
0
(HealthDay)—Younger people who are diagnosed with type 2 diabetes have higher weight and blood pressure (BP) than similarly aged people without diabetes, according to a study published online May 21 in Diabetologia.
Jun 3, 2020
0
1
An experimental drug helped significantly more overweight patients with diabetes shed pounds, compared with placebo, a new study finds. The results will be presented at The Endocrine Society's 94th Annual Meeting in Houston.
Jun 25, 2012
0
0
